[ studies on the fate of 5-fluoro-1,3-bis ( tetrahydro-2-furanyl ) -2,4-pyrimidinedione ( fd-1 ) , a new antitumor agent . i. absorption , distribution , excretion and metabolism of fd-1 administered orally to rats ( author 's transl ) ] .
C0221102
excretion
C0025519
metabolism